News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
EU Approves Two Applications for Datopotamab Deruxtecan in Advanced Nonsquamous Non-Small Cell Lung Cancer and HR Positive, HER2 Negative Breast Cancer Patients
Tuesday, March 05, 2024The European Medicines Agency has given its validation to two marketing authorization applications submitted by Daiichi Sankyo and AstraZeneca for their innovative drug datopotamab deruxtecan
A2 Bio Secures FDA Orphan Drug Designation for New Cell Therapy Program A2B530 Targeting Colorectal Cancer
Monday, March 04, 2024A Biotherapeutics Inc has recently revealed that their cell therapy product AB has secured Orphan Drug Designation from the US Food and Drug Administration for treating a specific subset of colorectal
Precisio Biotix Therapeutics Completes Acquisition of London-Based CC Bio, Strengthening Antibacterial Platform and Talent Roster
Saturday, March 02, 2024Precisio Biotix Therapeutics has recently announced the acquisition of CC Bio the creator of the ZEUS antibacterial lysin platform This acquisition is seen as a strategic move complementing Precisios
GENESIS Pharma Secures Exclusive Distribution Agreement with Regeneron Pharmaceuticals to Commercialize Cemiplimab in Greece, Cyprus, and Malta
Saturday, March 02, 2024GENESIS Pharma a regional biopharmaceutical company specializing in bringing innovative medicines for severe and rare diseases to Central and Eastern Europe has announced an exclusive distribution
Ariceum Therapeutics Granted Regulatory Approval in the UK for Phase I Clinical Trial of First-of-its-Kind Iodine-123 Labelled PARP Inhibitor in Patients with Recurrent Glioblastoma
Friday, March 01, 2024Ariceum Therapeutics a private biotech company specializing in the development of radiopharmaceutical products for the diagnosis and treatment of challenging cancers is pleased to
Alamar Biosciences and ALZpath, Inc. Announce Strategic Collaboration for pTau217 Antibody to Further Alzheimer's Disease Research
Friday, March 01, 2024Alamar Biosciences a company specializing in precision proteomics for early disease detection is excited to announce a strategic collaboration with ALZpath a prominent developer of diagnostic
PharmaKure and Sheffield Hallam University Collaborate to Investigate Epigenetic Mechanisms in Alzheimer's Disease
Friday, March 01, 2024PharmaKure a clinicalstage pharmaceutical company focusing on precision medicines for Alzheimers Disease and other neurodegenerative conditions has recently announced a new collaboration with
SCRI and AstraZeneca Partner to Drive Cancer Research through Technological Advancements and Innovative Operational Models
Thursday, February 29, 2024Sarah Cannon Research Institute a renowned oncology research organization specializing in communitybased clinical trials has announced a collaboration with AstraZeneca a global
Medidata and Thermo Fisher Scientific’s PPD Clinical Research Business Collaborate to Enhance Clinical Trials Innovation
Thursday, February 29, 2024Medidata a subsidiary of Dassault Systmes specializing in clinical trial solutions for the life sciences industry has recently announced the extension of its partnership with the PPD clinical research division
Skyhawk Therapeutics Progresses to Multiple Ascending Dose Phase in Phase 1 Trial of SKY-0515 Targeting Huntington's Disease
Thursday, February 29, 2024Skyhawk Therapeutics a biotechnology company in the clinical stage has initiated the Phase multiple ascending dose segment of its clinical study in Australia for SKY a small molecule candidate targeting
